| For: | Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World J Gastroenterol 2006; 12(28): 4445-4451 [PMID: 16874853 DOI: 10.3748/wjg.v12.i28.4445] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i28/4445.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Elemér Nemesánszky. Unfavourable laboratory results and hepatic disorders in pregnancy: causes and consequences. Orvosi Hetilap 2013; 154(29) doi: 10.1556/OH.2013.29635
|
| 3 |
Tomofumi Fujino, Kaori Murakami, Issei Ozawa, Yoshie Minegishi, Ryo Kashimura, Toshihiro Akita, Susumu Saitou, Takehisa Atsumi, Takashi Sato, Ken Ando, Shuntaro Hara, Kiyomi Kikugawa, Makio Hayakawa. Hypoxia downregulates farnesoid X receptor via a hypoxia‐inducible factor‐independent but p38 mitogen‐activated protein kinase‐dependent pathway. The FEBS Journal 2009; 276(5) doi: 10.1111/j.1742-4658.2009.06867.x
|
| 4 |
Sevtap Aydın, Mehmet Tokaç, Gökçe Taner, Ata Türker Arıkök, Halit Ziya Dündar, Alper Bilal Özkardeş, Mine Yavuz Taşlıpınar, Mehmet Kılıç, Arif Ahmet Başaran, Nurşen Başaran. Antioxidant and antigenotoxic effects of lycopene in obstructive jaundice. Journal of Surgical Research 2013; 182(2) doi: 10.1016/j.jss.2012.10.031
|
| 5 |
Ulrich Beuers, Gerd A. Kullak-Ublick, Thomas Pusl, Erik R. Rauws, Christian Rust. Medical Treatment of Primary Sclerosing Cholangitis: A Role for Novel Bile Acids and other (post-)Transcriptional Modulators?. Clinical Reviews in Allergy & Immunology 2009; 36(1) doi: 10.1007/s12016-008-8085-y
|
| 6 |
Dirk R. de Waart, Stephanie Häusler, Maria L.H. Vlaming, Cindy Kunne, Emanuel Hänggi, Hans-Jurgen Gruss, Ronald P.J. Oude Elferink, Bruno Stieger. Hepatic Transport Mechanisms of Cholyl-l-Lysyl-Fluorescein. The Journal of Pharmacology and Experimental Therapeutics 2010; 334(1) doi: 10.1124/jpet.110.166991
|
| 7 |
Duohu Wu, Chuanyu Bao, Longhe Li, Mingliang Fu, Desen Wang, Jinyuan Xie, Xiaoguang Gong. Chlorogenic acid protects against cholestatic liver injury in rats. Journal of Pharmacological Sciences 2015; 129(3) doi: 10.1016/j.jphs.2015.10.005
|
| 8 |
T.D. Zvyagintseva, I.I. Shargorod. Chronic acalculous cholecystitis: clinical features, diagnosis and treatment.. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2015; 2015(2) doi: 10.15407/internalmed2015.02.013
|
| 9 |
Mei Lan Chen, Kiyoshi Takeda, Mark S. Sundrud. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunology 2019; 12(4) doi: 10.1038/s41385-019-0162-4
|
| 10 |
Stephan von Haehling, Joerg C. Schefold, Ewa A. Jankowska, Jochen Springer, Ali Vazir, Paul R. Kalra, Anja Sandek, Günter Fauler, Tatjana Stojakovic, Michael Trauner, Piotr Ponikowski, Hans-Dieter Volk, Wolfram Doehner, Andrew J.S. Coats, Philip A. Poole-Wilson, Stefan D. Anker. Ursodeoxycholic Acid in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 2012; 59(6) doi: 10.1016/j.jacc.2011.10.880
|
| 11 |
Zeqi Wu, Jionghua Shi, Yue Zhang, Ruijia Shi, Qian Guo, Jingnan Zhang, Bin Lu, Zhenlin Huang, Lili Ji. Uncovering the pharmacological mechanism and the main herbal medicine contributing to the efficacy of Xiaoyanlidan Tablet (XYLDT) in treating cholestatic liver injury. Journal of Ethnopharmacology 2025; 340 doi: 10.1016/j.jep.2024.119163
|
| 12 |
Cen Guo, Lei He, Dan Yao, Jiye A, Bei Cao, Jin Ren, Guangji Wang, Guoyu Pan. Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes. Toxicology Letters 2014; 224(1) doi: 10.1016/j.toxlet.2013.09.019
|
| 13 |
Enver Reyhan, Mustafa Duman, Yeliz Demirci, Ali Emre Atici, Mahmut Ozer, Burcu Cevreli, Feza Ekiz, Tahsin Dalgic, Musa Akoglu, Ece Genc. Superiority of Ceftriaxon to Cefazolin in a Rat Model of Obstructive Jaundice: An Experimental Study. Journal of Investigative Surgery 2013; 26(1) doi: 10.3109/08941939.2012.687433
|
| 14 |
T. E. Polunina. Cholestasis: algorithms for diagnosis and treatment. Academy of medicine and sports 2022; 2(4) doi: 10.15829/2712-7567-2021-43
|
| 15 |
|
| 16 |
Nobuyuki Tamaki, Etsuro Hatano, Kojiro Taura, Masaharu Tada, Yuzo Kodama, Takashi Nitta, Keiko Iwaisako, Satoru Seo, Akio Nakajima, Iwao Ikai, Shinji Uemoto. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 294(2) doi: 10.1152/ajpgi.00482.2007
|
| 17 |
İsmail Bolat, Selçuk Özdemir, Selim Çomakli, Yavuz Selim Sağlam, Samet Tekin, Burak Çinar, Merve Bolat, Betül Orhan, Mustafa Erdem Sağsöz, Ufuk Okkay. Selenium pretreatment alleviates ANIT-induced cholestasis by preserving BSEP expression and hepatic redox homeostasis. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-12849-w
|
| 18 |
James L. Boyer. New perspectives for the treatment of cholestasis: Lessons from basic science applied clinically. Journal of Hepatology 2007; 46(3) doi: 10.1016/j.jhep.2006.12.001
|
| 19 |
Cynthia R.L. Webster, Johanna Cooper. Therapeutic Use of Cytoprotective Agents in Canine and Feline Hepatobiliary Disease. Veterinary Clinics of North America: Small Animal Practice 2009; 39(3) doi: 10.1016/j.cvsm.2009.02.002
|
| 20 |
Jean-Michel Vandeweerd, Carole Cambier, Pascal Gustin. Nutraceuticals for Canine Liver Disease. Veterinary Clinics of North America: Small Animal Practice 2013; 43(5) doi: 10.1016/j.cvsm.2013.05.003
|
| 21 |
Tingting Yang, Huifang Mei, Dengqiu Xu, Wang Zhou, Xiaoyu Zhu, Lixin Sun, Xin Huang, Xue Wang, Ting Shu, Jia Liu, Jiaxin Ding, H.M. Hassan, Luyong Zhang, Zhenzhou Jiang. Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis. Food and Chemical Toxicology 2017; 110 doi: 10.1016/j.fct.2017.09.051
|
| 22 |
Soyeon An, Eungyeong Jang, Jang-Hoon Lee, Sokcheon Pak. Preclinical Evidence of Curcuma longa and Its Noncurcuminoid Constituents against Hepatobiliary Diseases: A Review. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/8761435
|
| 23 |
Naoki Tanimizu, Atsushi Miyajima, Keith E. Mostov, Asma Nusrat. Liver Progenitor Cells Fold Up a Cell Monolayer into a Double-layered Structure during Tubular Morphogenesis. Molecular Biology of the Cell 2009; 20(9) doi: 10.1091/mbc.e08-02-0177
|
| 24 |
Jennifer M. Longpre, George Loo. Protection of human colon epithelial cells against deoxycholate by rottlerin. Apoptosis 2008; 13(9) doi: 10.1007/s10495-008-0244-3
|
| 25 |
Huanhuan Yu, Lulu Zhang, Pei Chen, Xiaofang Liang, Aizhi Cao, Juan Han, Xiufeng Wu, Yinhua Zheng, Yuchang Qin, Min Xue. Dietary Bile Acids Enhance Growth, and Alleviate Hepatic Fibrosis Induced by a High Starch Diet via AKT/FOXO1 and cAMP/AMPK/SREBP1 Pathway in Micropterus salmoides. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01430
|
| 26 |
Ranko Škrbić, Tatjana Milivojac, Milkica Grabež, Ljiljana Amidžić, Zorislava Bajic, Tanja Sobot, Nebojša Mandić-Kovačević, Snežana Uletilović, Đorđe Đukanović, Milica Gajic Bojic, Sanja Jovičić, Maja Barudžija, Nataša Vojinović, Miloš P. Stojiljković, Dragan M. Djuric, Hani Al-Salami, Sergey Bolevich, Momir Mikov. Ursodeoxycholic Acid Attenuates Lipopolysaccharide-Induced Myocardial Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis: The Interplay of Sirt1/Nrf2 and Akt/NF-κB Signaling Pathways. International Journal of Molecular Sciences 2026; 27(6) doi: 10.3390/ijms27062843
|
| 27 |
Omkar B. Ijare, Tedros Bezabeh, Nils Albiin, Urban Arnelo, Annika Bergquist, Bo Lindberg, Ian C.P. Smith. Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: A 1H MRS study. NMR in Biomedicine 2009; 22(5) doi: 10.1002/nbm.1355
|
| 28 |
Mehmet Tokaç, Gökçe Taner, Sevtap Aydın, Alper Bilal Özkardeş, Halit Ziya Dündar, Mine Yavuz Taşlıpınar, Ata Türker Arıkök, Mehmet Kılıç, Arif Ahmet Başaran, Nursen Basaran. Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstruction. Food and Chemical Toxicology 2013; 61 doi: 10.1016/j.fct.2013.01.015
|
| 29 |
Yanpeng Zhang, Hexiong Feng, Xu-Fang Liang, Shan He, Jie Lan, Ling Li. Dietary bile acids reduce liver lipid deposition via activating farnesoid X receptor, and improve gut health by regulating gut microbiota in Chinese perch (Siniperca chuatsi). Fish & Shellfish Immunology 2022; 121 doi: 10.1016/j.fsi.2022.01.010
|
| 30 |
Olga Martínez-Augustin, Fermín Sánchez de Medina. Intestinal bile acid physiology and pathophysiology. World Journal of Gastroenterology 2008; 14(37): 5630-5640 doi: 10.3748/wjg.14.5630
|
| 31 |
Gustav PAUMGARTNER. Pharmacotherapy of cholestatic liver diseases. Journal of Digestive Diseases 2010; 11(3) doi: 10.1111/j.1751-2980.2010.00427.x
|
| 32 |
Gustav Paumgartner, Thomas Pusl. Medical Treatment of Cholestatic Liver Disease. Clinics in Liver Disease 2008; 12(1) doi: 10.1016/j.cld.2007.11.013
|
| 33 |
|
| 34 |
Julia Waizenegger, Josephin Glück, Marcus Henricsson, Claudia Luckert, Albert Braeuning, Stefanie Hessel-Pras. Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis in the Human Hepatoma Cell Line HepaRG. Foods 2021; 10(1) doi: 10.3390/foods10010161
|
| 35 |
Katryn Allen, Nam Deuk Kim, Jeon-OK Moon, Bryan L. Copple. Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicology and Applied Pharmacology 2010; 243(1) doi: 10.1016/j.taap.2009.11.013
|
| 36 |
Tanaporn Khamphaya, Piyachat Chansela, Pawinee Piyachaturawat, Apichart Suksamrarn, Michael H. Nathanson, Jittima Weerachayaphorn. Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats. European Journal of Pharmacology 2016; 789 doi: 10.1016/j.ejphar.2016.07.032
|
| 37 |
R. G. MYAZIN. THE ROLE OF URSODEOXYCHOLIC ACID IN THE TREATMENT OF CHRONIC VIRAL HEPATITIS. Medical Council 2017; (4) doi: 10.21518/2079-701X-2017-4-31-35
|
| 38 |
Ruicong Sun, Chunjin Xu, Baisui Feng, Xiang Gao, Zhanju Liu. Critical roles of bile acids in regulating intestinal mucosal immune responses. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211018098
|
| 39 |
S. Stahl, M. R. Davies, D. I. Cook, M. J. Graham. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis. Xenobiotica 2008; 38(7-8) doi: 10.1080/00498250802105593
|
| 40 |
Debashree Debasish Das, Nikita Sharma, Pooja A Chawla. Current trends and future perspectives in the treatment of PBC and PSC: A review. Health Sciences Review 2022; 5 doi: 10.1016/j.hsr.2022.100065
|
| 41 |
V. Šmíd, T. Petr, K. Váňová, J. Jašprová, J. Šuk, L. Vítek, F. Šmíd, Lucie Muchová. Changes in Liver Ganglioside Metabolism in Obstructive Cholestasis – the Role of Oxidative Stress. Folia Biologica 2016; 62(4) doi: 10.14712/fb2016062040148
|
| 42 |
Somayeh Baghbaderani, Mohammad Nasehi, Mehrdad Hashemi. The expression studies of Bcl-xl gene subsequent effect of cholestasis and treatment by curcumin in hippocampus of male rats
. MEDICAL SCIENCES JOURNAL 2018; 28(1) doi: 10.29252/iau.28.1.37
|
| 43 |
Hanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, Michael Trauner. Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors. Molecular Pharmaceutics 2007; 4(6) doi: 10.1021/mp060133c
|
| 44 |
Qiao-ling Yang, Fan Yang, Jun-ting Gong, Xiao-wen Tang, Guang-yun Wang, Zheng-tao Wang, Li Yang. Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses. Acta Pharmacologica Sinica 2016; 37(9) doi: 10.1038/aps.2016.86
|
| 45 |
Azza S. Awad, Rehab Kamel. Effect of rosuvastatin on cholestasis‐induced hepatic injury in rat livers. Journal of Biochemical and Molecular Toxicology 2010; 24(2) doi: 10.1002/jbt.20315
|
| 46 |
Gaia Schiavon, Karel Eechoute, Ron H. J. Mathijssen, Peter de Bruijn, Jessica M. van der Bol, Jaap Verweij, Stefan Sleijfer, Walter J. Loos. Biliary Excretion of Imatinib and Its Active Metabolite CGP74588 During Severe Hepatic Dysfunction. The Journal of Clinical Pharmacology 2012; 52(7) doi: 10.1177/0091270011409235
|